From Casetext: Smarter Legal Research

Mylan Pharms. Inc. v. Eurand, Inc.

Supreme Court of the United States
Jan 14, 2013
568 U.S. 1123 (2013)

Opinion

No. 12–514.

2013-01-14

MYLAN PHARMACEUTICALS INC., et al., petitioners, v. EURAND, INC., nka Aptalis Pharmatech, Inc., et al.


Case below, 676 F.3d 1063.

Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit denied.


Summaries of

Mylan Pharms. Inc. v. Eurand, Inc.

Supreme Court of the United States
Jan 14, 2013
568 U.S. 1123 (2013)
Case details for

Mylan Pharms. Inc. v. Eurand, Inc.

Case Details

Full title:MYLAN PHARMACEUTICALS INC., et al., petitioners, v. EURAND, INC., nka…

Court:Supreme Court of the United States

Date published: Jan 14, 2013

Citations

568 U.S. 1123 (2013)
133 S. Ct. 933
184 L. Ed. 2d 725
81 U.S.L.W. 3251